Heparin/Lidocaine (intravesical)
Treatment for Interstitial Cystitis
Effectiveness
62%
Safety Score
75%
Clinical Trials
8
Participants
1.5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
0
Heparin/Lidocaine (intravesical) Outcomes
for Interstitial Cystitis
Efficacy Outcomes
Overall Effectiveness
+62%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
3 active trials recruiting for Heparin/Lidocaine (intravesical) in Interstitial Cystitis
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
NCT05737121RECRUITINGPHASE2
120 participants
INTERVENTIONAL
Escondido, United States +13 more
Started: May 22, 2023
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
NCT06394830RECRUITINGPHASE2
50 participants
INTERVENTIONAL
Tucson, United States +4 more
Started: Dec 13, 2024
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
NCT02870738ACTIVE NOT RECRUITINGPHASE2
128 participants
INTERVENTIONAL
Royal Oak, United States
Started: Apr 21, 2017
Completed Clinical Trials
2 completed trials for Heparin/Lidocaine (intravesical) in Interstitial Cystitis
Study of U101 for Bladder Pain and/or Urgency
NCT00256542COMPLETEDPHASE2
90 participants
INTERVENTIONAL
San Diego, United States +8 more
Started: Jan 1, 2006
Clinical Trial Comparing Two Bladder Instillations for IC/BPS
NCT03463915COMPLETEDPHASE3
90 participants
INTERVENTIONAL
Louisville, United States
Started: Jan 25, 2019